title: Cystoid macular edema associated with fingolimod use for multiple sclerosis.
authors.affiliation: Departments of Ophthalmology and Visual Science, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA.
authors.forename: Armin R
authors.initials: AR
authors.lastname: Afshar
authors.forename: Joshua K
authors.initials: JK
authors.lastname: Fernandes
authors.forename: Ravi D
authors.initials: RD
authors.lastname: Patel
authors.forename: Susan M
authors.initials: SM
authors.lastname: Ksiazek
authors.forename: Veeral S
authors.initials: VS
authors.lastname: Sheth
authors.forename: Anthony T
authors.initials: AT
authors.lastname: Reder
authors.forename: Seenu M
authors.initials: SM
authors.lastname: Hariprasad
mesh_terms: D000284:Administration, Oral; D005260:Female; D000068876:Fingolimod Hydrochloride; D005451:Fluorescein Angiography; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects*; D012189:Retrospective Studies; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D041623:Tomography, Optical Coherence; D014792:Visual Acuity / Q000502:physiology
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine